Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine and rhesus-rotavirus-based quadrivalent vaccine
- 1 August 1990
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 336 (8711), 330-334
- https://doi.org/10.1016/0140-6736(90)91876-c
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Rhesus Rotavirus Candidate VaccineAmerican Journal of Diseases of Children, 1990
- Field trial of rhesus rotavirus vaccine in infantsThe Pediatric Infectious Disease Journal, 1988
- Systemic and mucosal immune responses to rhesus rotavirus vaccine MMU 18006The Pediatric Infectious Disease Journal, 1988
- TRIAL OF AN ATTENUATED BOVINE ROTAVIRUS VACCINE (RIT 4237) IN GAMBIAN INFANTSThe Lancet, 1987
- PROTECTION AGAINST SEVERE ROTAVIRUS DIARRHOEA BY RHESUS ROTAVIRUS VACCINE IN VENEZUELAN INFANTSThe Lancet, 1987
- FAILURE OF LIVE, ATTENUATED ORAL ROTAVIRUS VACCINEThe Lancet, 1986
- Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity.Proceedings of the National Academy of Sciences, 1985
- Serotypic Similarity and Diversity of Rotaviruses of Mammalian and Avian Origin as Studied by Plaque-Reduction NeutralizationThe Journal of Infectious Diseases, 1984
- PROTECTION OF INFANTS AGAINST ROTAVIRUS DIARRHOEA BY RIT 4237 ATTENUATED BOVINE ROTAVIRUS STRAIN VACCINEThe Lancet, 1984
- Rotavirus shedding by newborn childrenJournal of Medical Virology, 1984